Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Population structure and spatio-temporal transmission dynamics of Plasmodium vivax after radical cure treatment in a rural village of the Peruvian Amazon.

Delgado-Ratto C, Soto-Calle VE, Van den Eede P, Gamboa D, Rosas A, Abatih EN, Rodriguez Ferrucci H, Llanos-Cuentas A, Van Geertruyden JP, Erhart A, D'Alessandro U.

Malar J. 2014 Jan 6;13:8. doi: 10.1186/1475-2875-13-8.

2.

Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon.

Van den Eede P, Van der Auwera G, Delgado C, Huyse T, Soto-Calle VE, Gamboa D, Grande T, Rodriguez H, Llanos A, Anné J, Erhart A, D'Alessandro U.

Malar J. 2010 Jun 3;9:151. doi: 10.1186/1475-2875-9-151.

3.

Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia.

Orjuela-Sánchez P, da Silva NS, da Silva-Nunes M, Ferreira MU.

Am J Trop Med Hyg. 2009 Dec;81(6):961-8. doi: 10.4269/ajtmh.2009.09-0337.

4.

Genetic variation and recurrent parasitaemia in Peruvian Plasmodium vivax populations.

McCollum AM, Soberon V, Salas CJ, Santolalla ML, Udhayakumar V, Escalante AA, Graf PC, Durand S, Cabezas C, Bacon DJ.

Malar J. 2014 Feb 24;13:67. doi: 10.1186/1475-2875-13-67.

5.

Plasmodium vivax sub-patent infections after radical treatment are common in Peruvian patients: results of a 1-year prospective cohort study.

Van den Eede P, Soto-Calle VE, Delgado C, Gamboa D, Grande T, Rodriguez H, Llanos-Cuentas A, Anné J, D'Alessandro U, Erhart A.

PLoS One. 2011 Jan 28;6(1):e16257. doi: 10.1371/journal.pone.0016257.

6.

Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community.

Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, Alvarez E, Perez EJ, Gotuzzo E.

Malar J. 2005 Jun 23;4:27.

7.

Active case detection, treatment of falciparum malaria with combined chloroquine and sulphadoxine/pyrimethamine and vivax malaria with chloroquine and molecular markers of anti-malarial resistance in the Republic of Vanuatu.

Kinzer MH, Chand K, Basri H, Lederman ER, Susanti AI, Elyazar I, Taleo G, Rogers WO, Bangs MJ, Maguire JD.

Malar J. 2010 Apr 6;9:89. doi: 10.1186/1475-2875-9-89.

8.

Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.

Rishikesh K, Kamath A, Hande MH, Vidyasagar S, Acharya RV, Acharya V, Belle J, Shastry AB, Saravu K.

Malar J. 2015 Aug 11;14:310. doi: 10.1186/s12936-015-0824-y.

9.

Severe Plasmodium vivax malaria, Brazilian Amazon.

Alexandre MA, Ferreira CO, Siqueira AM, Magalhães BL, Mourão MP, Lacerda MV, Alecrim Md.

Emerg Infect Dis. 2010 Oct;16(10):1611-4. doi: 10.3201/eid1610.100685.

10.

Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon.

Grietens KP, Soto V, Erhart A, Ribera JM, Toomer E, Tenorio A, Montalvo TG, Rodriguez H, Cuentas AL, D'Alessandro U, Gamboa D.

Am J Trop Med Hyg. 2010 Jun;82(6):1017-23. doi: 10.4269/ajtmh.2010.09-0521.

11.

[Characterization of Plasmodium vivax malaria transmission at the border of Panamá and Costa Rica].

Cáceres L, Rovira J, Torres R, García A, Calzada J, De La Cruz M.

Biomedica. 2012 Oct-Dec;32(4):557-69. doi: 10.1590/S0120-41572012000400011. Spanish.

12.

In vivo therapeutic efficacy of chloroquine alone or in combination with primaquine against vivax malaria in Kolkata, West Bengal, India, and polymorphism in pvmdr1 and pvcrt-o genes.

Ganguly S, Saha P, Guha SK, Das S, Bera DK, Biswas A, Kundu PK, Saha B, Ray K, Maji AK.

Antimicrob Agents Chemother. 2013 Mar;57(3):1246-51. doi: 10.1128/AAC.02050-12. Epub 2012 Dec 21.

13.
14.

Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.

Kim JR, Nandy A, Maji AK, Addy M, Dondorp AM, Day NP, Pukrittayakamee S, White NJ, Imwong M.

PLoS One. 2012;7(7):e39645. doi: 10.1371/journal.pone.0039645. Epub 2012 Jul 13.

15.

Genetic diversity and population structure of Plasmodium vivax in Central China.

Liu Y, Auburn S, Cao J, Trimarsanto H, Zhou H, Gray KA, Clark TG, Price RN, Cheng Q, Huang R, Gao Q.

Malar J. 2014 Jul 9;13:262. doi: 10.1186/1475-2875-13-262.

16.

In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.

Hwang J, Alemayehu BH, Reithinger R, Tekleyohannes SG, Takele Teshi, Birhanu SG, Demeke L, Hoos D, Melaku Z, Kassa M, Jima D, Malone JL, Nettey H, Green M, Poe A, Akinyi S, Udhayakumar V, Kachur SP, Filler S.

PLoS One. 2013 May 22;8(5):e63433. doi: 10.1371/journal.pone.0063433. Print 2013.

17.

Treatment of vivax malaria on the western border of Thailand.

Luxemburger C, van Vugt M, Jonathan S, McGready R, Looareesuwan S, White NJ, Nosten F.

Trans R Soc Trop Med Hyg. 1999 Jul-Aug;93(4):433-8.

PMID:
10674098
18.

Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.

Khattak AA, Venkatesan M, Khatoon L, Ouattara A, Kenefic LJ, Nadeem MF, Nighat F, Malik SA, Plowe CV.

Malar J. 2013 Sep 5;12:310. doi: 10.1186/1475-2875-12-310.

19.

Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.

Yeshiwondim AK, Tekle AH, Dengela DO, Yohannes AM, Teklehaimanot A.

Acta Trop. 2010 Feb;113(2):105-13. doi: 10.1016/j.actatropica.2009.10.001. Epub 2009 Oct 14.

PMID:
19835832
20.

Chloroquine-resistant Plasmodium vivax malaria in Peru.

Ruebush TK 2nd, Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR, Marquiño W, Huilca M, Arévalo E, Garcia C, Solary L, Kain KC.

Am J Trop Med Hyg. 2003 Nov;69(5):548-52.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk